JBR-201
Measles Virus, Herpes Virus, Potential: EBV, HIV, HPV, Broad Respiratory Viruses
PreclinicalActive
Key Facts
Indication
Measles Virus, Herpes Virus, Potential: EBV, HIV, HPV, Broad Respiratory Viruses
Phase
Preclinical
Status
Active
Company
About Jupiter BioMedical Research
Jupiter Biomedical Research is a preclinical-stage biotech focused on developing novel small molecule therapeutics for oncology and virology. Its lead asset, JBR-102, is being developed as an oral formulation for glioblastoma and other solid and hematologic tumors, while JBR-201 is an antiviral candidate with potential activity against a broad spectrum of viruses. The company appears to be a private, pre-revenue entity with a management team listed on its website but no disclosed clinical data, investors, or partners, indicating an early-stage venture seeking to advance its candidates into clinical development.
View full company profile